Predicting Influenza Infections during Epidemics with Use of a Clinical Case Definition
Open Access
- 15 November 2000
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (5), 1166-1169
- https://doi.org/10.1086/317425
Abstract
Combined pharyngeal and nasal swab specimens were collected from 100 subjects who presented with a flu-like illness (fever>37.8°C plus 2 of 4 sympKeywords
This publication has 18 references indexed in Scilit:
- Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute InfluenzaJAMA, 2000
- Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human InfluenzaJAMA, 1999
- Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infectionsThe Lancet, 1998
- The predictive value of influenza symptomatology in elderly peopleFamily Practice, 1998
- New Approaches to Influenza ChemotherapyDrugs, 1998
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus InfectionsNew England Journal of Medicine, 1997
- Respiratory Syncytial Virus and Influenza A Infections in the Hospitalized ElderlyThe Journal of Infectious Diseases, 1995
- Studies of the Community and Family: Acute Respiratory Illness and InfectionEpidemiologic Reviews, 1994
- 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitroAntimicrobial Agents and Chemotherapy, 1993
- Viral Respiratory Infections in the Institutionalized Elderly: Clinical and Epidemiologic FindingsJournal of the American Geriatrics Society, 1992